Not a glove maker yet

'To be' glove maker

@KYY
Higher EPS of Supermax does not mean, the company is better than Hartalega , Topglove or Kossan.

Factors such as no of share issued is also a consideration. Topglove issued more shares which has a larger denominator than Supermax, thus the lower EPS.
If Topglove has the same no of shares issued as Supermax, the current EPS would be more than RM1.0.

Rather the focus should be the company's annual net profit

Actually back then before CNY 2020, Supermax was trading at lower PE of 12 as compared its peers: Topglove (pe=30), Kossan (pe=25), Harta (pe=45)

It's more like investor began to see that it's undervalued and the PE now is reflecting better than previously.

Define better?

1QFY2021 will be released on 09 December 2020

https://www.topglove.com/corporate-calendar/

Topglove: What will Topglov be reporting Q3 profit?


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-18-story-h1536493634-Topglove_What_will_Topglov_be_reporting_Q3_profit.jsp

Topglove: What will Topglov be reporting Q3 profit?


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-18-story-h1536493634-Topglove_What_will_Topglov_be_reporting_Q3_profit.jsp

Topglove: What will Topglov be reporting Q3 profit?


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-18-story-h1536493634-Topglove_What_will_Topglov_be_reporting_Q3_profit.jsp

Topglove: What will Topglov be reporting Q3 profit?


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-18-story-h1536493634-Topglove_What_will_Topglov_be_reporting_Q3_profit.jsp

Topglove: What will Topglov be reporting Q3 profit?


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-18-story-h1536493634-Topglove_What_will_Topglov_be_reporting_Q3_profit.jsp

for those in 10th floor, I suggest keep the stock, enjoy the company's large expansion to 40++ bil glove production in 2 years, get rewarded with dividends and bonus issues in the future if you believe the company's long term growth.

Unless, you have desperate need to use the money you had put into this counter.

Good write up.
Simple and on the spot.
It's really up to individual investor to decide their entry & exit.
Long term investors > 5 years normally do well.

Unlike KYY who is not an investor as he seems more like a trader which I do not recommend as there is volatility in the short term nature of glove stocks and pharma stocks.

Whoever prefers to buy vaccine, buy pharma related counters
Whoever prefer gloves, buy glove counters.
Whoever think both are good, buy both pharma and gloves
Whoever think both are over, sell everything

I don't see the point of arguing over it.

Topglove had updated the CBP status in the annual report on 12/11.

Dividends had been declared on 23/9 and paid on 3/11.

Which part you are not clear?

https://de.reuters.com/article/us-health-coronavirus-vaccines-distribut/why-pfizers-ultra-cold-covid-19-vaccine-will-not-be-at-the-local-pharmacy-any-time-soon-idUSKBN27P2VI

Pfizer vaccine needs to be at minus 70-80 degrees celcius

Yusen Gold Cold can handled up to minus 20 degrees celcius


https://www.yusen-logistics.com/en/industries/healthcare-logistics/

Our capabilities include dedicated and managed fleets with temperature-control capabilities and secure GDP compliant temperature controlled hubs. These controlled temperature (15–25°C), cold storage (2–8°C) and frozen storage (<–20°C) facilities allow us to offer warehouse capacity for a range of pharmaceutical and biopharmaceutical products.

https://de.reuters.com/article/us-health-coronavirus-vaccines-distribut/why-pfizers-ultra-cold-covid-19-vaccine-will-not-be-at-the-local-pharmacy-any-time-soon-idUSKBN27P2VI

Pfizer vaccine needs to be at minus 70-80 degrees celcius

Yusen Gold Cold can handled up to minus 20 degrees celcius


https://www.yusen-logistics.com/en/industries/healthcare-logistics/

Our capabilities include dedicated and managed fleets with temperature-control capabilities and secure GDP compliant temperature controlled hubs. These controlled temperature (15–25°C), cold storage (2–8°C) and frozen storage (<–20°C) facilities allow us to offer warehouse capacity for a range of pharmaceutical and biopharmaceutical products.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3097777

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3097777

Expected this to happne when you rush to develop this vaccine in 6 months which normally takes at least 2-3 years and some 4-5 years.

I'm fairly confident that after the vaccine is developed, very few ppl will want to be vaccinated as they are afraid of the unknown adverse affects of it.

Just like software release of Alpha/Beta version, most ppl would wait for the official release.

Ask yourself a question where Supermax will be 10 years from now.

@Steve Ooi

It's President Biden's mandate during his election campaign to procure PPE using his Executive Order.

https://www.cnbc.com/2020/10/23/joe-biden-lays-out-a-detailed-plan-to-fight-coronavirus-.html

@Airline Bobby

You're another individual negative of glove based on all your comments.
I'm publishing based on facts and I did not give a timeline as no one knows.

One key point for sure is WRP Asia case took 6 months to revoke, thus is a good benchmark since Topglove had engaged the same consultant that helps WRP Asia to solve the same issue.

@limkt88
You only have 7 comments and mostly negative towards glove.
CBP is enforced by customs department and is govern by the executive order of the President of United States of America.

With new president in placed, commissioner's office will likely be replaced with Biden's team.

Topglove: New president Biden will bring changes to US CBP decision


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-08-story-h1535688373-Topglove_New_president_Biden_will_bring_changes_to_US_CBP_decision.jsp

Topglove: New president Biden will bring changes to US CBP decision


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-08-story-h1535688373-Topglove_New_president_Biden_will_bring_changes_to_US_CBP_decision.jsp

Topglove: New president Biden will bring changes to US CBP decision


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-08-story-h1535688373-Topglove_New_president_Biden_will_bring_changes_to_US_CBP_decision.jsp

Topglove: New president Biden will bring changes to US CBP decision


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-08-story-h1535688373-Topglove_New_president_Biden_will_bring_changes_to_US_CBP_decision.jsp

Topglove: New president Biden will bring changes to US CBP decision


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-08-story-h1535688373-Topglove_New_president_Biden_will_bring_changes_to_US_CBP_decision.jsp

Topglove: New president Biden will bring changes to US CBP decision


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-08-story-h1535688373-Topglove_New_president_Biden_will_bring_changes_to_US_CBP_decision.jsp

Topglove: New president Biden will bring changes to US CBP decision


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-08-story-h1535688373-Topglove_New_president_Biden_will_bring_changes_to_US_CBP_decision.jsp

KYY is re-writing and re-producing old data.
The 1st slides is like 4-5months old.
There are newer data already out on Supermax in October.
Is there something wrong with him?

To be honest, Monday should be positive for glove stocks as most industry experts are looking at least RM2.4 billion for extraordinary profit taxation.

With no windfall taxation lingering, most investors have peace of mind till 2022 and beyond.

https://themalaysianreserve.com/2020/11/04/glove-industry-to-pay-higher-corporate-taxes-says-no-to-windfall-tax/

Expecting monday to move closer to RM9 and above in view of positive outcome from Budget 2021 and Covid-19 negative outlook worldwide.

KUALA LUMPUR (Nov 6): Top Glove Corp Bhd, Hartalega Holdings Bhd and Supermax Corp Bhd have confirmed that they are donating to the Government’s COVID-19 fund set up to battle the pandemic.

When contacted by theedgemarkets.com, Top Glove said it is donating RM185 million to the fund, while Supermax will be chipping in RM75 million.

Meanwhile, Hartalega said in a statement that it will be contributing RM90 million to the fund.

“This is a corporate social responsibility initiative by Hartalega to make a positive difference in the lives of Malaysians and support the nation’s healthcare sector,” it said.

Their total contributions amount to RM350 million.

This follows the tabling of Budget 2021 this afternoon, whereby Finance Minister Tengku Datuk Seri Zafrul Aziz announced that that the three glove makers, in addition to Kossan Rubber Industries Bhd, have committed to donate RM400 million to the COVID-19 fund.

The money will be used to cover part of the cost of vaccines and health equipment expenses, said the Minister.

https://www.theedgemarkets.com/article/top-glove-hartalega-and-supermax-confirm-donations-govts-rm400-mil-covid19-fund

the breakdown does not have a proper source?

Budget 2021: Top Glove, other rubber glove manufacturers pledge RM400m to assist Covid-19 fight, including for vaccines

A small contribution to the society should be applause, NO WINDFALL TAX

Topglove is more transparent with their orderbook than supermax as the company indicates the exact month and year. So that investor will be assured.

Topglove: Overwhelming Demand For Nitrile Glove

https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-05-story-h1535632544-Topglove_Overwhelming_Demand_For_Nitrile_Glove.jsp

Topglove: Overwhelming Demand For Nitrile Glove

https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-05-story-h1535632544-Topglove_Overwhelming_Demand_For_Nitrile_Glove.jsp

Topglove: Overwhelming Demand For Nitrile Glove

https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-05-story-h1535632544-Topglove_Overwhelming_Demand_For_Nitrile_Glove.jsp

Topglove: Overwhelming Demand For Nitrile Glove

https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-05-story-h1535632544-Topglove_Overwhelming_Demand_For_Nitrile_Glove.jsp

Topglove: Overwhelming Demand For Nitrile Glove

https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-05-story-h1535632544-Topglove_Overwhelming_Demand_For_Nitrile_Glove.jsp

Topglove: Overwhelming Demand For Nitrile Glove


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-05-story-h1535632544-Topglove_Overwhelming_Demand_For_Nitrile_Glove.jsp

@ ahbah

To be honest, many people are promoting vaccines and that glove's demand will reduce significantly will be proven wrong.

Vaccine wannabies are thinking after 1-2 doses of vaccine, the individual will be 100% immune to covid-19. It's very sad to see these understandings.

Anyway, glove will still continue to produce after covid-19 war but vaccine for covid-19 will definitely die a natural death since vaccine wannabies believe everyone is cured in the end.

The other thing abt taxation and raw material cost increase, normally glove manufacturers will just pass the cost on to customers.

In other words, there is no impact on the glove companies.

@ soonheng

Where do you get the information from?

Though it is not announce on Bursa Malaysia.

It seems unlikely to have windfall tax as the government had not met with MARGMA and the leaders for consultation.

Besides that, many industry experts and IBs are expecting this supernormal profit period to end by mid next year once the vaccine is fully commercialized.

Thus, it would be foolish and a slap to their own face to table a tax in Budget 2021 that last for only 6 months.

Seems the more KYY writes, the lower the price.

Notice also that when he's quiet, Supermax shares are soaring.

Why Supermax?
There is the other 3 large manufacturer like Toglove, Hartalega and Kossan are also into nitrile glove.

@ ahbah
This article is to reveal that one of the vaccine manufacturer is confessing that long term mask is still needed.
Thus, PPE including glove will still be the main solution for Covid-19 even with vaccine.

Not that vaccine will not work, but production and logistic are not ready to vaccinate 8 billion ppl.

Even if both production and logistic are ready, the vaccine efficacy may not be effective.

Even if vaccine efficacy is efficient/perfect, a person vaccinated can still be infected with covid-19.

So that's the point that glove WILL surpass most IBs estimate for 2022's demand to normalise, at least till 2024/2025.